Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Study examines effects of higher NSAIDs dosages
Researchers test if higher doses alleviate foot pain in horses

A study carried out by researchers in America has examined whether higher-than-standard doses of non-steroidal anti-inflammatory drugs (NSAIDs) alleviate foot pain more efficiently.

To test this hypothesis, Jonathan Foreman DVM, MS, Dipl. ACVIM and his colleagues at the University of Illinois at Urbana-Champaign used a reversible heart bar shoe to allow sound horses to become temporarily lame. The pain subsides completely when researchers loosen the screw in the shoe to relieve foot pressure.

When the researchers tighten the screw in the shoe the pain level increases, as reflected by increasing heart rates. Following the regional anaesthesia application, the horses' heart rates dropped from 60 to 40 beats per minute (bpm).

In this study the scientists compared the effects of varying intravenous doses (half-dose, 1x, 2x) of flunixin meglumine; they used saline as a control. Ten sound horses wore a reversible heart bar shoe on the front left foot. Following treatment, the 1x and 2x doses improved heart rates for the 12-hour duration, whereas heart rates remained elevated in the control horses.

Heart rates in the horses given half-doses of flunixin did not decrease as much as those in the 1x and 2x horses, and they didn't remain low for as long. "They responded intermittently and not as obviously," Foreman commented. There was no difference in heart rate results between the horses receiving 1x or 2x flunixin meglumine.

Foreman concluded that the double dose was no more effective than the single dose and presented a higher risk of toxicity. The half-dose was less effective than the single dose; therefore, you can't rely on an anti-endotoxic half-dose to provide complete pain control for horses with painful hoof conditions such as laminitis.

Foreman summed the study up by saying: "More is not better and less is less effective."


Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.